Fig. 8From: A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in GermanyResult of the probabilistic sensitivity analysis: incremental cost-effectiveness and 95% confidence ellipse, timeframe lifetime, men; base case: starting age 75 years oldBack to article page